Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin vs Silodosin + Vibegron for Storage Symptoms in BPH
jRCT1061240018Recruiting
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in benign prostatic hyperplasia (BPH) and overactive bladder (OAB) comparing Silodosin monotherapy with Silodosin + vibegron combination (2 arms). Started Jun 2024; status: recruiting.
02
Drugs
silodosinvibegron
03
Conditions
benign prostatic hyperplasia (BPH)overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT1061240018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1061240018.